An Online Intervention Targeting Depression and Low Reward Sensitivity

October 2, 2023 updated by: Philipps University Marburg Medical Center

Evaluation of an Online Intervention Targeting Depression and Low Reward Sensitivity - A Randomized Controlled Trial

This study aims to evaluate and compare the effectiveness of different online interventions targeting reward sensitivity and depressive symptoms. We hypothesize that behavioral activation, a mindfulness and gratitude intervention, as well as a combination of both, will significantly reduce depressive symptoms and increase reward sensitivity, compared to the waitlist group. In addition, we assume that behavioral activation will have an increased effect on reward sensitivity compared to the mindfulness and gratitude intervention.

The investigators will further investigate factors influencing treatment success in another paper based on data of this study (see secondary and other pre-specified outcome measures).

Study Overview

Detailed Description

Depression is characterized by low reward sensitivity, which is a potential maintaining factor of depressive symptoms. This is why treatment for depression should include evidence-based interventions that target reward insensitivity. Up until now, there is a lack of research that studies reward sensitivity as main outcome measure or focus of interventions, especially in the online format. However, it is crucial to identify psychological interventions that are most effective in treating low reward sensitivity. Previous studies showed that behavioral activation can be a powerful intervention to increase the availability of rewards in everyday life. In addition, mindfulness-based interventions offer effective interventions with regards to low reward sensitivity since mindfulness refocusses attention on the present moment.

This study aims to evaluate the effectiveness of different online interventions compared to a waitlist control condition in a randomized controlled trial. The sample will include participants with mild to moderate depressive symptoms, who have been preselected for their low trait reward responsiveness. Inclusion and exclusion criteria will be confirmed via a preliminary online survey and a telephone screening, which will be administered by a trained psychologist. Suicidal participants or participants who suffer from severe depression will be excluded. Those will be informed about possibilities to get intensive professional help. Further exclusion criteria will be an ongoing psychotherapy, an antidepressant medication which has been taken for a shorter time period than four weeks, persons with a lifetime diagnosis of bipolar disorder (I and II), psychotic disorders or a substance use disorder.

Participants will be randomly assigned into four groups. The randomization will be stratified according to their depression score (mild or moderate). The investigators aim to include 50 participants per group (N = 200 in total). The first group ("Behavioral Activation") will be instructed to include daily positive activities and fill out a mood protocol, which covers the time period shortly before, during and after the activity. The second group ("Mindfulness and Gratitude") will fill out a mindfulness diary and reflect upon daily pleasant situation via revisiting the impressions of their five senses during this situation. In addition, participants will specify how long they have dealt with the situation and will name something they are grateful for. The third group will do a combination of the two interventions. The fourth group will be the waitlist control condition and receive the intervention material of the third group after two weeks.

Participants will receive a pre-intervention online survey with questionnaires as a baseline measurement. This survey includes a psychoeducation video and an instruction video explaining the intervention rationale and the daily excercises. Participants will receive working sheets to protocol their daily exercises over a course of two weeks. In addition, participants are encouraged to report their results and possible problems with the implementation of the excercises in a short online survey. In addition, every day a different case study will be presented which deals with obstacles and shows strategies to solve problems. Furthermore, participants are able to contact the principal contact person of the study (Laura Potsch) via telephone to help with problems. After two weeks of daily interventions, participants will receive a post-questionnaire to measure treatment effects and will receive a follow up questionnaire after 4 months.

Study Type

Interventional

Enrollment (Actual)

224

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Marburg, Germany, 35037
        • Philipps University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18 or above
  • Fluent in German
  • Informed consent
  • Depressive symptoms (PHQ-9 > 5)

Exclusion Criteria:

  • suicidality, severe depression
  • current or lifetime: substance use disorder, psychotic disorders, bipolar I or II
  • current psychotherapy
  • if antidepressant medication: has not been stable over the last 4 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral Activation
14 days of daily excercises
  • instruction to create a list of individual positive activities.
  • instruction to include daily positive activities and fill out a mood protocol, which covers the time period shortly before, during and after the activity.
Experimental: Mindfulness and Gratitude
14 days of daily excercises
  • instruction to fill out a mindfulness diary: reflection of daily pleasant situation, instructing the participants to revisit the impressions of their 5 senses during this situation, in addition they should specify how long they have actually dealt with these pleasant impressions of the situation they reflected upon
  • instruction to do a gratitude exercise and name one or more things they are generally grateful for each day.
Experimental: Combination: Behavioral Activation and Mindfulness and Gratitude
14 days of daily excercises
This group will do a combination of the two intervention types.
No Intervention: Waitlist control group
Will receive the intervention (combination) after two weeks of intervention time of the other groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in depressive symptoms (Patient Health Questionnaire-9, PHQ-9)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from 0 to 3 (0 = not at all; 1 = several days; 2 = more than a week; 3 = nearly every day).
  • PHQ-9 total score ranges from 0 to 27 (classification of scores: 5-9 mild depression; 10-14 as moderate depression; 15-19: moderately severe depression; 20 - 27 severe depression).
  • Consequently, a higher score means worse depressive symptoms.
baseline, post intervention (after 2 weeks), 4 months follow up
Change in reward sensitivity (Positive Valence System Scale-21, PVSS-21)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from 1 to 9 (1 = extremely untrue of me, 2 = very untrue of me, 3 = moderately untrue of me, 4 = slightly untrue of me, 5 = neutral, 6 = slightly true of me, 7 = moderately true of me, 8 = very true of me, 9 = extremely true of me).
  • PVSS-21 total score ranges from 21 to 189.
  • Consequently, a higher score means a higher reward responding.
baseline, post intervention (after 2 weeks), 4 months follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Somatization psychopathology (Patient Health Questionnaire-15, PHQ-15)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow up
  • Items in the PHQ-15 range from 0 to 2 (0 = not bothered at all, 1 = bothered a little, 2 = bothered a lot), two items (which are included in the PHQ-9 (question 2c and d) originally range from 0 to 3 (0 = not at all; 1 = several days; 2 = more than a week; 3 = nearly every day), here 2 and 3 are counted as 2.
  • PHQ-15 total score ranges from 0 to 30 (classification of scores: ≥5 mild level of somatization, ≥10 moderate level of somatization, ≥15 severe level of somatization).
  • Consequently, a higher score means a worse somatization.
Baseline, post intervention (after 2 weeks), 4 months follow up
Generalized anxiety disorder psychopathology (Generalizied Anxiety Disorder Scale-7, GAD-7)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from 0 to 3 (0 = not at all, 1 = several days, 2 = more than half the days, 3 = nearly every day).
  • GAD-7 total score ranges from 0 to 21 (classification of scores: 0 - 4: no to low risk, 5 - 9: mild, 10 - 14: moderate, >= 15 severe).
  • Consequently, a higher score means a worse generalized anxiety disorder psychopathology.
Baseline, post intervention (after 2 weeks), 4 months follow up
Eating disorder psychopathology (Eating Disorder Examination-Questionnaire-8, EDE-Q-8)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from 0 to 6 (0 = characteristic was not present to 6 = characteristic was present every day or in extreme form).
  • Subscale scores (restraint, eating concern, weight concern, shape concern), as well as a total score can be calculated, the total score ranges from 0 to 48.
  • Consequently, a higher score means a worse eating disorder psychopathology.
Baseline, post intervention (after 2 weeks), 4 months follow up
Social anxiety disorder psychopathology (Mini-Social Phobia Inventory, Mini-SPIN)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from 0 to 4 (0 = not at all, 1 = a little bit, 2 = somewhat, 3 = very much, 4 = extremely).
  • Mini-Spin total score ranges from 0 to 12.
  • Consequently, a higher score means a worse social anxiety disorder psychopathology.
Baseline, post intervention (after 2 weeks), 4 months follow up
Treatment expectation (Generic Rating for Treatment Pre-Experiences, Treatment Expectations, and Treatment Effects, G-EEE)
Time Frame: Baseline, post intervention (after 2 weeks)
- Items range from 0 to 10 (depending on the item from "no improvement" to "greatest improvement imaginable", from "no worsening" to "greatest worsening imaginable", from "no complaints" to "greatest complaints imaginable") and one item, where previous treatment experience is assessed via a choice of "I have never experienced this treatment." (continue with question 8), "I have experienced this treatment during the last 12 months (nearly) daily.", "I have experienced this treatment during the last 12 months on more than 10 days.", "I have experienced this treatment during the last 12 months on about 5 to 10 days.", I have experienced this treatment during the last 12 months on about 1 to 4 days." And "I have not experienced this treatment during the last 12 months, but I have experienced it before."
Baseline, post intervention (after 2 weeks)
Treatment credibility and expectancy (Credibility/Expectancy Questionnaire, CEQ)
Time Frame: Baseline
  • Items range from 1 to 9 (Item 1 of Set 1: 1= not at all logical, 5 = somewhat logical, 9 = very logical, Item 2 of Set 1: 1= not at all useful, 5 = somewhat useful, 9 = very useful, Item 3 of Set 1: 1 = not at all confident, 5 = somewhat confident, 9 = very confident, Item 1 of Set 2: 1 = not at all, 5 = somewhat, 9 = very much), Item 4 of Set 1 and Item 2 of Set 2 give a choice of 0% to 100% in steps of 10 %.
  • CEQ composite score can be derived for each factor (expectancy and credibility)
Baseline
Trait reward responsiveness (Reward Responsiveness Scale, RRS)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from 1 to 4 (1= strong disagreement, 2 = mild disagreement, 3 = mild agreement, 4 = strong agreement)
  • RRS total score ranges from 8 to 32.
  • Consequently, a higher score means a higher reward responsiveness.
Baseline, post intervention (after 2 weeks), 4 months follow up
Stress level (Perceived-Stress-Scale 10, PSS-10)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from 1 to 5 (1= never, 2 = almost never, 3 = sometimes, 4 = fairly often, 5 = very often) Items 4, 5, 7 and 8 are reverse scored for the total score.
  • PH=perceived helplessness subscale; PSE=perceived self-efficacy subscale
  • PH subscale is computed by summing up Items 1, 2, 3, 6, 9 and 10; the PSE subscale is computed by summing up items 4, 5, 7 and 8
  • PSS-10 total score is the sum of all PH and reversed PSE items
  • Consequently, a higher score means a greater level of stress.
Baseline, post intervention (after 2 weeks), 4 months follow up
Anhedonia (Snaith-Hamilton-Pleasure-Scale, SHAPS-D)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from "Definitely Agree", "Agree", "Disagree", and "Strongly Disagree". Either of the "Disagree responses" receive a score of 1 and either of the "Agree responses" receive a score of 0.
  • SHAPS-D total score ranges from 0 to 14.
  • Consequently, a higher score means a greater state anhedonia.
Baseline, post intervention (after 2 weeks), 4 months follow up
Depressive expectations (Depressive Expectations Scale, DES)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow up
  • Items range from 1 to 5 (1 = I disagree , 2 = I partially disagree, 3 = neutral, 4 = I partially agree, 5 = I agree).
  • DES total score ranges from 25 to 125
  • Consequently, a higher score means more dysfunctional depressive expectations.
Baseline, post intervention (after 2 weeks), 4 months follow up
Personality traits (Big Five Inventory 10, BFI-10)
Time Frame: Baseline, post intervention (after 2 weeks), up to four months follow up
  • Items range from 1 (disagree strongly) to 5 (agree strongly).
  • Scales: openness to experience, conscientiousness, extraversion, agreeableness and neuroticism
Baseline, post intervention (after 2 weeks), up to four months follow up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: post intervention (after 2 weeks), 4 months follow up
  • Number of completed online surveys regarding the intervention exercises (T1 to T14: daily online surveys over the course of two weeks)
  • Self report of implementation of daily excercises in post intervention survey and follow up survey.
post intervention (after 2 weeks), 4 months follow up
Influence of type of positive activity/type of pleasant situation
Time Frame: during daily excercises (14 days)
- Type of activities and reflected pleasant situations that have been selected in the daily online surveys (e.g. social, sports ...)
during daily excercises (14 days)
Problems and obstacles during the intervention
Time Frame: post intervention (after 2 weeks), 4 months follow up
- Frequency of telephone contacts made with the principal contact person (Laura Potsch) and specified problems with the implementation of the daily excercises in the daily online survey
post intervention (after 2 weeks), 4 months follow up
Sociodemographic variables
Time Frame: baseline
- Gender, age, education, employment, medication, self report lifetime diagnosis of psychiatric conditions, previous experience with psychotherapy etc.
baseline
Perceived system usability (System usability Scale, SUS), general feedback about the online intervention
Time Frame: post intervention (after 2 weeks)
  • Items of the SUS range from 1 to 5 (1= strongly disagree to 5 = strongly agree).
  • After a computation, the SUS score can range from 0 to 100. A SUS score above a 68 is considered above average.
  • general feedback about the online intervention: free text entries about the online intervention: criticism, change requests, praise, one closed question: "Would you recommend the online intervention to someone else?" Yes/No
post intervention (after 2 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Winfried Rief, Prof. Dr., Dept. of Clinical Psychology and Psychotherapy, Philipps-University Marburg, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2022

Primary Completion (Actual)

May 15, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

May 23, 2022

First Submitted That Met QC Criteria

May 30, 2022

First Posted (Actual)

June 2, 2022

Study Record Updates

Last Update Posted (Actual)

October 3, 2023

Last Update Submitted That Met QC Criteria

October 2, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression Moderate

Clinical Trials on Behavioral Activation

3
Subscribe